fura-2 has been researched along with Prostatic Neoplasms in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mas-Oliva, J; Navarro-Vidal, E; Tapia-Vieyra, JV | 1 |
| Chang, HT; Chen, WC; Chou, CT; Fang, YC; Hsu, SS; Huang, JK; Jan, CR; Kuo, CC; Kuo, DH; Liao, WC; Shieh, P; Tsai, JY; Wang, BW | 1 |
| Chang, HT; Chen, IS; Chou, CT; Ho, CM; Huang, JK; Jan, CR; Kuo, CC; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Shu, SS; Tsai, JY; Wang, JL | 1 |
| Chang, HT; Chen, IS; Cheng, JS; Chou, CT; Hsu, SS; Jan, CR; Kuo, CC; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Tsai, JY; Wang, JL | 1 |
| Chou, CT; Hsu, SS; Huang, JK; Jan, CR; Kuo, CC; Liang, WZ; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Tsai, JY | 1 |
| Bonnal, JL; Lepage, G; Mariot, P; Mauroy, B; Prevarskaya, N; Roudbaraki, M; Shuba, Y; Skryma, R; Vanden Abeele, F; Vanoverberghe, K | 1 |
| Chao, YY; Jan, CR | 1 |
| Chang, HT; Chen, JS; Chen, WC; Cheng, HH; Cheng, JS; Hsu, SS; Huang, JK; Jan, CR; Jiann, BP; Lo, YK; Yeh, JH | 1 |
| Chang, HT; Chen, JS; Chen, WC; Cheng, HH; Hsu, SS; Huang, CJ; Huang, JK; Jan, CR; Jiann, BP | 1 |
| Chang, CH; Chang, HT; Chen, WC; Chou, CT; Hsieh, CH; Hsu, SS; Huang, JK; Jan, CR; Liu, CS; Liu, SI | 1 |
| Chen, IS; Cheng, HH; Chou, CT; Chu, ST; Hsu, SS; Huang, CJ; Jan, CR; Kuo, CC; Lin, KL; Liu, SI; Lu, YC; Tseng, LL; Wang, JL | 1 |
| Dubi, N; Fishman, D; Gheber, L; Hershfinkel, M; Sekler, I | 1 |
| Audin, J; Cantereau, A; Dufy, B; Georgescauld, D; Perret, S | 1 |
| Devoll, RE; Farach-Carson, MC; Lecrone, V; Li, W; Logothetis, C | 1 |
| Huang, JK; Jan, CR | 1 |
| Dewailly, E; Humez, S; Legrand, G; Mariot, P; Prevarskaya, N; Slomianny, C; Vanden Abeele, F; Wuytack, F | 1 |
| Chang, HT; Chen, WC; Chou, KJ; Huang, JK; Jan, CR; Law, YP; Lee, KC; Lo, YK; Su, W; Tang, KY; Wang, JL | 1 |
| Chang, HT; Chen, WC; Huang, JK; Jan, CR; Jiann, BP; Lu, YC; Su, W; Yu, CC | 1 |
| Reinach, P; Socci, R; Steinsapir, J | 1 |
19 other study(ies) available for fura-2 and Prostatic Neoplasms
| Article | Year |
|---|---|
ARP2, a novel pro-apoptotic protein expressed in epithelial prostate cancer LNCaP cells and epithelial ovary CHO transformed cells.
Topics: Angiopoietin-Like Protein 2; Angiopoietin-like Proteins; Angiopoietins; Animals; Apoptosis; Calcium; Caspase 3; Caspase 7; Cell Line, Transformed; Cell Line, Tumor; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Cytosol; Enzyme Activation; Female; Fura-2; Gene Expression; Humans; Male; Ovary; Prostatic Neoplasms; Protein Transport | 2014 |
Effect of diallyl disulfide on Ca2+ movement and viability in PC3 human prostate cancer cells.
Topics: Allyl Compounds; Antineoplastic Agents; Apoptosis; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Survival; Cytosol; Disulfides; Drug Screening Assays, Antitumor; Fura-2; Humans; Male; Prostatic Neoplasms; Reactive Oxygen Species | 2011 |
Effect of thapsigargin on Ca²+ fluxes and viability in human prostate cancer cells.
Topics: Apoptosis; Aristolochic Acids; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Survival; Estrenes; Fluorescence; Fura-2; Humans; Intracellular Space; Male; Manganese; Prostatic Neoplasms; Pyrrolidinones; Thapsigargin; Type C Phospholipases | 2011 |
Effect of celecoxib on Ca(2+) handling and viability in human prostate cancer cells (PC3).
Topics: Calcium; Calcium Channels, L-Type; Celecoxib; Cell Death; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Fluorescent Dyes; Fura-2; Humans; Male; Phospholipases A2; Prostatic Neoplasms; Pyrazoles; Sulfonamides | 2012 |
Effect of diindolylmethane on Ca2+ homeostasis and viability in PC3 human prostate cancer cells.
Topics: Calcium; Calcium Signaling; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum; Fura-2; Homeostasis; Humans; Indoles; Male; Prostatic Neoplasms; Thapsigargin; Type C Phospholipases | 2012 |
Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells.
Topics: Apoptosis; Blotting, Western; Calcium; Calcium Channels; Calcium-Transporting ATPases; Calreticulin; Cell Differentiation; Cell Line, Tumor; Electric Capacitance; Electric Impedance; Electrophysiology; Endoplasmic Reticulum; Epithelial Cells; Fluorescent Dyes; Fura-2; Homeostasis; Humans; Kinetics; Male; Models, Biological; Neurosecretory Systems; Patch-Clamp Techniques; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Thapsigargin; Tumor Necrosis Factor-alpha | 2004 |
Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells.
Topics: Adenosine Triphosphate; Azepines; Calcium; Calcium Signaling; Cell Proliferation; Dihydropyridines; Diltiazem; Enzyme Inhibitors; Fura-2; Humans; Male; Phorbol Esters; Platelet Membrane Glycoproteins; Prostatic Neoplasms; Protein Kinase C; Receptors, G-Protein-Coupled; Signal Transduction; Thapsigargin; Triazoles; Tumor Cells, Cultured; Verapamil | 2004 |
Effect of the antidepressant maprotiline on Ca2+ movement and proliferation in human prostate cancer cells.
Topics: Antidepressive Agents, Second-Generation; Calcium; Cell Division; Cell Line, Tumor; Cell Survival; Fluorescent Dyes; Fura-2; Humans; Male; Maprotiline; Prostatic Neoplasms; Type C Phospholipases | 2004 |
Nordihydroguaiaretic acid-induced Ca2+ handling and cytotoxicity in human prostate cancer cells.
Topics: Antineoplastic Agents; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Division; Cell Line, Tumor; Cell Survival; Colorimetry; Fluorescent Dyes; Fura-2; Humans; Lipoxygenase Inhibitors; Male; Masoprocol; Prostatic Neoplasms; Solutions; Type C Phospholipases | 2004 |
NPC-14686 (Fmoc-l-homophenylalanine)-induced CaCa2+ increases and death in human prostate cancer cells.
Topics: Aminobutyrates; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Death; Cell Division; Cell Line, Tumor; Fluorescent Dyes; Fura-2; Humans; Male; Manganese; Prostatic Neoplasms; Tetrazolium Salts; Type C Phospholipases | 2006 |
Desipramine-induced Ca2+ movement and cytotoxicity in PC3 human prostate cancer cells.
Topics: Antidepressive Agents; Calcium; Calcium Signaling; Cell Survival; Chelating Agents; Desipramine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fura-2; Humans; Male; Prostatic Neoplasms; Thapsigargin | 2007 |
Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells.
Topics: Animals; Calcium; Calcium Signaling; Cell Proliferation; Cell Survival; Enzyme Activation; Fura-2; Humans; Immunoblotting; Male; Mice; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostatic Neoplasms; Receptors, Cell Surface; Signal Transduction; Tumor Cells, Cultured; Zinc Compounds | 2008 |
Interplay between Ca2+ release and Ca2+ influx underlies localized hyperpolarization-induced [Ca2+]i waves in prostatic cells.
Topics: Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Polarity; Electric Stimulation; Enzyme Inhibitors; Fura-2; Gadolinium; Humans; Lanthanum; Male; Manganese; Microscopy, Confocal; Nimodipine; Prostatic Neoplasms; Ryanodine; Thapsigargin; Tumor Cells, Cultured | 1999 |
Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins.
Topics: Adenosine Triphosphate; Animals; Bone Morphogenetic Proteins; Bone Neoplasms; Brain Neoplasms; Calcium Signaling; Chemical Fractionation; Fluorescent Dyes; Fura-2; Humans; Lymphatic Metastasis; Male; Osteonectin; Osteopontin; Prostatic Neoplasms; Prothrombin; Rats; Receptors, Vitronectin; Sialoglycoproteins; Thrombin; Tissue Extracts; Tumor Cells, Cultured | 2000 |
Mechanism of estrogens-induced increases in intracellular Ca(2+) in PC3 human prostate cancer cells.
Topics: Antineoplastic Agents, Hormonal; Calcium; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Diethylstilbestrol; Enzyme Inhibitors; Estradiol; Estrenes; Fluorescent Dyes; Fura-2; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Pyrrolidinones; Thapsigargin; Tumor Cells, Cultured; Uncoupling Agents | 2001 |
Ca2+ pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases 2B involvement in human prostate cancer cell growth control.
Topics: Blotting, Western; Calcium; Calcium-Transporting ATPases; Cell Division; Chelating Agents; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Fluorescent Dyes; Fura-2; Humans; Immunohistochemistry; Intracellular Membranes; Male; Microscopy, Fluorescence; Microsomes; Prostatic Neoplasms; Protein Binding; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Spectrophotometry; Thapsigargin; Time Factors; Tumor Cells, Cultured | 2001 |
Mechanism underlying histamine-induced intracellular Ca2+ movement in PC3 human prostate cancer cells.
Topics: Calcium; Calcium-Transporting ATPases; Endoplasmic Reticulum; Enzyme Inhibitors; Estrenes; Fluorescent Dyes; Fura-2; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Inositol 1,4,5-Trisphosphate; Ion Transport; Male; Phosphodiesterase Inhibitors; Prostatic Neoplasms; Pyrilamine; Pyrrolidinones; Thapsigargin; Tumor Cells, Cultured; Type C Phospholipases | 2001 |
Effect of the organotin compound triethyltin on Ca2+ handling in human prostate cancer cells.
Topics: Calcium; Calcium-Transporting ATPases; Dose-Response Relationship, Drug; Drug Antagonism; Fura-2; Humans; Male; Nicardipine; Nifedipine; Nimodipine; Prostatic Neoplasms; Thapsigargin; Triethyltin Compounds; Tumor Cells, Cultured | 2002 |
Effects of androgen on intracellular calcium of LNCaP cells.
Topics: Calcium; Cell Line; Dihydrotestosterone; Fura-2; Humans; Kinetics; Male; Nandrolone; Prostatic Neoplasms; Spectrometry, Fluorescence; Testosterone Congeners; Time Factors; Verapamil | 1991 |